Literature DB >> 25594651

Granulocyte colony-stimulating factor-producing cholangiocellular carcinoma.

Kazuhiro Suzumura1, Yuji Iimuro, Tadamichi Hirano, Yasukane Asano, Nobukazu Kuroda, Toshihiro Okada, Shogo Tanaka, Keiji Nakasho, Jiro Fujimoto.   

Abstract

A 61-year-old female was admitted to our hospital with epigastric pain and fever. The laboratory data showed severe inflammatory reactions. Computed tomography revealed an irregular tumor in the left hepatic lobe and swelling of lymph nodes. (18)F-fluorodeoxy-glucose positron emission tomography (FDG-PET) showed high uptake by the tumor, with diffuse uptake in the spine. Based on the elevated leukocyte count and FDG-PET findings, the patient was diagnosed with a granulocyte colony-stimulating factor (G-CSF)-producing tumor (G-CSF, 213 pg/mL). We performed left trisegmentectomy of the liver, bile duct resection, and lymph node dissection. Histologically, the tumor was a poorly differentiated adenocarcinoma with some lymph nodes metastasis. Immunohistochemical staining of the tumor cells was positive for G-CSF. Therefore, the tumor was diagnosed as G-CSF-producing cholangiocellular carcinoma. The inflammatory reactions and serum G-CSF level transiently improved immediately after surgery. However, 1 month later, the leukocyte count and serum G-CSF level increased again, and recurrence was observed in the remnant liver. The patient died 3 months after the operation. G-CSF-producing cholangiocellular carcinoma is rare. This tumor progresses rapidly, and surgical treatment for advanced condition should be carefully selected.

Entities:  

Keywords:  Cholangiocellular carcinoma; FDG-PET; Granulocyte colony-stimulating factor; Immunohistochemistry; Leukocytosis

Mesh:

Substances:

Year:  2015        PMID: 25594651      PMCID: PMC4301276          DOI: 10.9738/INTSURG-D-13-00183.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  10 in total

1.  [An autopsy case of cholangiocellular carcinoma producing granulocyte colony-stimulating factor].

Authors:  J Masuda; K Omagari; T Nomoto; H Hazama; K Ohba; K Yamaguchi; H Kinoshita; K Murase; S Katayama; I Sekine; S Kohno
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2000-03

2.  [An autopsy case of intrahepatic cholangiocarcinoma producing granulocyte-colony stimulating factor].

Authors:  K Kakinoki; Y Takemori; Y Noda; M Hoso
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2000-09

3.  Postoperative aggravation of hypercalcemia-leukocytosis syndrome in a case of squamous cell type cholangiocarcinoma.

Authors:  M Aizawa; H Koshiyama; D Inoue; Y Fukunaga; H Katakami; M Miki; Y Mizuno
Journal:  Intern Med       Date:  1997-03       Impact factor: 1.271

4.  The secretion of cytokines and granulocyte colony stimulating factor by anaplastic and poorly differentiated thyroid carcinoma cell lines.

Authors:  H Asakawa; T Kobayashi
Journal:  Anticancer Res       Date:  1999 Jan-Feb       Impact factor: 2.480

5.  Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue.

Authors:  S Asano; A Urabe; T Okabe; N Sato; Y Kondo
Journal:  Blood       Date:  1977-05       Impact factor: 22.113

6.  Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression.

Authors:  M M Mueller; C C Herold-Mende; D Riede; M Lange; H H Steiner; N E Fusenig
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

7.  Cholangiocellular carcinoma that produced both granulocyte-colony-stimulating factor and parathyroid hormone-related protein.

Authors:  Tetsuro Sohda; Hiroshi Shiga; Hidetoshi Nakane; Hiroshi Watanabe; Morishige Takeshita; Shotaro Sakisaka
Journal:  Int J Clin Oncol       Date:  2006-06       Impact factor: 3.402

8.  Granulocyte-colony stimulating factor-producing gallbladder cancer without recurrence more than 2 years after resection: report of a case.

Authors:  Tetsuo Ikeda; Kippei Ohgaki; Masatoku Miura; Shinichi Aishima; Toshihisa Shimizu; Yoshihiko Maehara
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

9.  Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.

Authors:  Y Sugawara; S J Fisher; K R Zasadny; P V Kison; L H Baker; R L Wahl
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

10.  Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor.

Authors:  M Tachibana; A Miyakawa; H Tazaki; K Nakamura; A Kubo; J Hata; T Nishi; Y Amano
Journal:  Cancer Res       Date:  1995-08-01       Impact factor: 12.701

  10 in total
  3 in total

1.  Intrahepatic sarcomatoid cholangiocarcinoma: A case report of the youngest patient on record and a review of the condition's characteristics.

Authors:  Long-Fu Xi; Yun Jin; Jiang-Tao Li
Journal:  Front Surg       Date:  2022-09-01

Review 2.  G-CSF in tumors: Aggressiveness, tumor microenvironment and immune cell regulation.

Authors:  Ioannis Karagiannidis; Eralda Salataj; Erika Said Abu Egal; Ellen J Beswick
Journal:  Cytokine       Date:  2021-03-04       Impact factor: 3.926

Review 3.  Imaging findings of granulocyte colony-stimulating factor-producing tumors: a case series and review of the literature.

Authors:  Shigeshi Kohno; Akihiro Furuta; Shigeki Arizono; Koji Tokunaga; Sei Nakao; Masahiro Tanabe; Tatsuki R Kataoka; Hiroyoshi Isoda; Kaori Togashi
Journal:  Jpn J Radiol       Date:  2021-05-22       Impact factor: 2.374

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.